Drugs of addiction lead to a wide range of epigenetic changes at the promoter regions of genes directly implicated in learning and memory processes. We have previously shown that the histone deactylase inhibitor, sodium butyrate (NaB), accelerates the extinction of nicotine-seeking and provides resistance to relapse. Here, we explore the potential molecular mechanisms underlying this effect. Rats received intravenous nicotine or saline self-administration, followed by 6 days of extinction training, with each extinction session followed immediately by treatment with NaB or vehicle. On the last day of extinction, rats were killed and the medial ventral prefrontal cortex retained for chromatin immunoprecipitation and quantitative polymerase chain reaction (qPCR). A history of nicotine exposure significantly decreased H3K14 acetylation at the brain-derived neurotrophic factor (BDNF) exon IV promoter, and this effect was abolished with NaB treatment. In contrast, nicotine self-administration alone, resulted in a significant decrease in histone methylation at the H3K27me3 and H3K9me2 marks in the promoter regions of BDNF exon IV and cyclin-dependent kinase 5 (Cdk-5). Quantitative PCR-identified changes in several genes associated with NaB treatment that were independent of nicotine exposure; however, an interaction of nicotine history and NaB treatment was detected only in the expression of BDNF IV and BDNF IX. Together these results suggest that nicotine self-administration leads to a number of epigenetic changes at both the BDNF and Cdk-5 promoters, and that these changes may contribute to the enhanced extinction of nicotine-seeking by NaB.
Recurrent relapse to cigarette smoking is a principal characteristic of tobacco addiction. This is due in part to the ability of nicotine to facilitate the formation of strong and enduring drug-associated memories which continue to prompt relapse during abstinence (Gould & Leach 2014) . The mechanisms that support the persistence of these memories are not well understood, but may involve epigenetic regulation of gene expression.
We have previously showed that in rats trained to intravenously self-administer nicotine, extinction of nicotine-seeking can be enhanced by the post-session injection of the histone deacetylase inhibitor (HDACi) sodium butyrate (NaB) (Castino et al. 2015) . When tested for reinstatement, this enhanced extinction learning results in a significant attenuation of relapse. Notably, this effect was not evident in rats trained to self-administer a natural reward. These results suggest that exposure to nicotine across self-administration leads to epigenetic modifications that may influence later susceptibility to relapse. The nature of such changes is currently unknown, but is likely to include nicotine-induced chromatin modifications.
Drugs of abuse, including nicotine, lead to widespread changes to the epigenome, including the post-translational modifications of histone proteins (Levine et al. 2011; Nestler 2014) . The most widely studied of these changes is histone acetylation. Acetylation of lysine residues by histone acetyltransferases on the N-terminus of histone proteins results in a relaxed chromatin structure that promotes gene transcription. In contrast, removal of acetyl-groups by histone deacetylase enzymes (HDACs) leads to a closed chromatin state, and a repression of gene transcription. Histone acetylation interacts with other epigenetic modifications including histone methylation, where addition of methyl-groups to lysine and arginine residues is catalysed via histone methyltransferases, resulting in either transcriptionally permissive (H3K4me2) or repressive (H3K9me2 and H3K27me3) chromatin, depending on the methylation target (Young et al. 2011) .
Increasing evidence indicates that administration of nicotine either in vitro or in vivo leads to a relaxed chromatin state (Chase & Sharma 2013; Landais et al. 2005; Levine et al. 2011; Satta et al. 2008) . Exactly how nicotine influences chromatin structure is not clear, however, nicotine is associated with an overall reduction in HDAC activity, a global increase in both total H3 and H4 acetylation, and gene-specific increases in histone acetylation in the promoter regions of key gene loci implicated in drug addiction [e.g. FosB; (Levine et al. 2011)] . Results from in vitro studies also show that nicotine inhibits histone methyltransferase expression, leading to decreases in methylation of the repressive mark H3K9me2 in the promoter regions of learning-associated genes (e.g. brain-derived neurotrophic factor: BDNF), and that appears to be mediated via activity at the nicotinic acetylcholine receptor (nAChR) (Chase & Sharma 2013) . The effect of nicotine on these epigenetic processes has yet to be investigated in an ecologically valid paradigm, such as drug self-administration, where changes in gene expression due to learning may be occurring against a background of epigenetic changes induced by nicotine exposure.
The aim of this study was to examine epigenetic modifications that persist across the extinction of intravenous nicotine self-administration, and that may underlie the effects of NaB-potentiated extinction of nicotine-seeking behaviour (Castino et al. 2015) . We examined changes in histone acetylation, histone methylation and messenger RNA (mRNA) of genes previously associated with drug addiction and/or the maintenance of long-term memories, in tissue derived from the ventromedial prefrontal cortex (vmPFC; containing the infralimbic cortex), a brain area that is critical for the extinction of learned associations (Bredy et al. 2007; Laurent & Westbrook 2009 ) and involved in exerting inhibitory control over drug-seeking (Peters et al. 2008) .
Materials and methods

Subjects
Twenty-four male Sprague Dawley rats (175-200 g; Animal Resource Centre, WA, Australia) were housed four per cage on a 12-h reverse light/dark cycle (lights off at 0700). Rats received ad libitum access to food and water until 2 days prior to nicotine self-administration when food was reduced to 22 g/rat/day. All testing was carried out during the dark cycle.
Procedures described were approved by The Animal Care and Ethics Committee of the University of New South Wales (12/155B) and were conducted in accordance with the Australian Code for the Care and Use of Animals for Scientific Purposes (8th ed.). All possible measures were taken to minimize pain or discomfort of animals.
Drugs
Nicotine hydrogen tartrate and NaB (Sigma, MO, USA) were dissolved in sterile saline (0.9% NaCl). All doses of nicotine refer to the free base form.
Nicotine intravenous self-administration (IVSA)
All rats underwent surgery for the implantation of a chronic intravenous catheter as described previously (Macnamara et al. 2016) . Following recovery from surgery, behavioural training began with two daily 1 h habituation sessions conducted in standard self-administration equipment [Med Associates, VT, USA; (Macnamara et al. 2016) ] with nose-pokes covered and the house-light on.
Rats were then randomly assigned to receive nicotine (Nic) or saline (Sal) self-administration for 12 days on a fixed ratio-1 schedule of reinforcement. Self-administration sessions lasted for 1 h and began with the illumination of the house-light. Each response on the active nose-poke resulted in a single infusion of nicotine (30 μg/kg/100 μl; 3 seconds) or saline (100 μl over 3 seconds), presentation of the cue-light inside the nose-poke (3 seconds) and termination of the house-light (20 seconds). Responses during the 20-second time-out period or on the inactive nose-poke were recorded but were of no scheduled consequence.
Following self-administration training, all rats underwent six daily extinction sessions, where responses on the active nose-poke were recorded but were of no scheduled consequence. Based on performance across the last 3 days of acquisition (active and inactive nose-pokes), rats were allocated to receive an intraperitoneal injection of either NaB (100 mg/kg; 1 ml/kg) or vehicle (Veh; saline; 1 ml/kg) administered immediately after the session. This resulted in four groups of six rats: Nic/NaB, Nic/Veh, Sal/NaB and Sal/Veh.
We investigated chromatin modifications and gene expression at the conclusion of the final extinction session for three reasons: (1) in order to interrogate lasting changes that are not due to acute drug effects (i.e. after a drug-primed reinstatement test), (2) where behavioural performance will be equivalent (level of responding is similar across groups on the final day of extinction) and (3) following a procedure that leads to a significant attenuation of subsequent reinstatement in NaB-treated rats (Castino et al. 2015) .
Tissue preparation
Thirty minutes after the final extinction session rats were anaesthetised with pentobarbitone sodium (325 mg/ml/rat) before brains were rapidly removed and the vmPFC (containing the infralimbic cortex, 2 mm 2 ; bregma: 5.16 -2.76 mm) dissected onto dry ice using a scalpel blade. The vmPFC was selected due to its involvement in the extinction of learned associations (Bredy et al. 2007; Laurent & Westbrook 2009) and inhibitory control over drug-seeking (Peters et al. 2008) .
Brain tissue was homogenized in 1 ml ice cold phosphate buffered saline (PBS) using a glass dounce tissue grinder. Separate aliquots from the same sample were taken for the analysis of chromatin immunoprecipitation (ChIP) assay and RNA expression.
ChIP assay
Homogenized vmPFC tissue was incubated in 1% formaldehyde for 5 min at room temperature before quenching with 0.125 M glycine. Tissue was washed twice with ice-cold PBS containing protease inhibitor cocktail tablets (PIs; Roche, NSW, Australia) and resuspended in sodium dodecyl sulphate (SDS) lysis buffer (1% SDS, 10 mM ethylenediaminetetraacetic acid [EDTA] , 50 mM Tris hydrochloride [Tris-HCl], pH 8.0) with PIs. After incubation on ice for 5 min, brain lysates were sheared using an ultrasonicator (Covaris S220, MA, USA; 5% duty, 4 intensity, 200 cycles/burst, 25 cycles of 60 seconds) to achieve DNA fragments of 200-1000 bp (confirmed on agarose gel). Sonicated lysate was then centrifuged (12 000 g for 20 min at 4 ∘ C) to remove debris.
Antibodies specific to H3K14ac (07-353, Millipore), H3K4me3, (Ab8898, Abcam), H3K27me3 (Ab6002, Abcam) or H3K9me2 (Ab1220, Abcam) were precleared for 2 h at 4 ∘ C with Dynabeads Protein G (ThermoFisher) and ChIP dilution buffer (CDB; 0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris -HCl, pH 8.0, and 167 mM NaCl). Beads containing bound antibody were then washed and incubated overnight (4 ∘ C on a rotating platform) in sample lysate diluted 1:2 with CDB containing PIs. To ensure the specificity of antibody binding, a parallel immunoprecipitation was performed with a normal rabbit immunoglobulin G (IgG; catalogue # 2719; Cell Signalling Technology, MA, USA), which precipitated negligible levels of DNA for the genes analysed. A further sample diluted with CDB was used as Input (i.e. non-immunoprecipitated) as a measure of starting DNA.
Following incubation, chromatin-antibody-bead complexes were washed three times each with low-salt buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl, pH 8.0, 150 mM NaCl) and high-salt buffer (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl, pH 8.0, 500 mM NaCl). Formaldehyde cross-links were reversed in immunoprecipitated and Input samples by heating to 95 ∘ C (4 h on a rotation stand), before proteins were digested with proteinase K (40 μg; 45 min, 50 ∘ C; Invitrogen, CA, USA).
DNA was recovered with a phenol/chloroform extraction and ethanol precipitation (phenol:chloroform:isoamyl alcohol at 25:24:1) then centrifuged for 15 min at 12 000 g (4 ∘ C). The resultant supernatant was incubated overnight (−80 ∘ C) in 100% ethanol (× 2 the volume of the supernatant), glycogen and 5 M NaCl. Samples were centrifuged (12 000 g; 15min at 4 ∘ C), before pellets were washed with 75% ethanol, air dried and eluted with nuclease-free water.
ChIP qPCR
Levels of H3K14ac, H3K4me3, H3K27me3 and H3K9me2 at regions of the BDNF IV and cyclin-dependent kinase 5 (Cdk-5) promoters were targeted due to previous associations with memory consolidation (Levenson et al. 2004) , NaB treatment (Raybuck et al. 2013; Stafford et al. 2012) , chronic psychostimulant administration (Damez-Werno et al. 2012; Feng et al. 2014; Malvaez et al. 2011; Wang et al. 2010 ) and evidence of regulation by nicotine in vitro (Chase & Sharma 2013) .
Targets of interest were measured using quantitative polymerase chain reaction (qPCR) (95 ∘ C for 30 seconds, followed by 40 cycles of 95 ∘ C for 3 seconds and 60 ∘ C for 30 seconds). For each target, relative enrichment was calculated as a percentage of corresponding Input. A table of primers used for ChIP can be found in Table 1 .
RNA extraction and qPCR for gene expression
RNA was isolated using the Trzol extraction method according to manufacturer's instructions (Invitrogen). Messenger RNA was DNase-treated and reverse transcribed in a C1000 Touch Thermal Cycler (Bio-Rad Laboratories, CA, USA) using the QuantiTect Reverse Transcription Kit (Qiagen, CA, USA) according to the manufacturer's instructions.
Quantitative PCR was performed in a StepOnePlus system with the use of SYBR Select Master Mix (Applied Biosystems, VIC, Australia). All qPCR primers (Integrated DNA Technologies, IA, USA) were designed using Primer3 software (Untergasser et al. 2012) and verified using the BLAST-like alignment tool (BLAT; Kent 2002) . Annealing temperatures for each primer were optimized using temperature-graded PCR, before specificity for target sequences confirmed with 1.5% agarose gels. Primer efficiencies were also determined using a standard curve.
Targets for gene expression studies were selected based on our ChIP data (BDNF and Cdk-5), with the inclusion of additional plasticity-related genes previously shown to be altered following chronic drug administration [FosB: (Levine et al. 2011)] or are involved in the epigenetic regulation of memory formation following drugs of abuse [Nr4a1, Nr4a2, NPAS4; (Freeman et al. 2008; Martin et al. 2012; Rogge et al. 2013) ]. For each target (run-in triplicate for each sample), mRNA levels were normalized to the housekeeping-gene GAPDH. A list of primers used can be found in Table 2 .
Statistical analysis
All data were analysed using mixed model ANOVA, repeated measures ANOVA or t-tests as appropriate. Significant main effects or interactions were followed up with Bonferroni corrected post hoc analyses. For qPCR data, when the Ct SD of triplicates was greater than 0.5, the outlier was identified and excluded. Data points beyond 2 SDs of the mean were excluded as outliers.
Results
Nicotine self-administration
As illustrated in Fig. 1 , rats receiving nicotine rapidly acquired the self-administration response. This was evident as an increase in responses on the active nose-poke in rats self-administering nicotine [main effect of operandum: (F 1,20 ) = 27.84, P < 0.001; operandum by drug infusion interaction: (F 1,20 ) = 16.94, P < 0.001], that developed across training days [day by drug infusion interaction: (F 11,220 ) = 6.73, P < 0.001], and that did not differ between groups subsequently treated with NaB (Fs < 1.6).
There was an overall decrease in responding with the onset of extinction training (last day of IVSA vs. last day of extinction, (F 1,20 ) = 51.82, P < 0.001) and this difference was greatest in the rats self-administering nicotine [(F 1,20 ) = 26.70, P < 0.001]. Across extinction training days, there was a significant decrease in overall responding [(F 5,100 ) = 4.95, P < 0.001], although this was not significantly impacted by treatment with NaB. This is consistent with our past results using this same extinction procedure: an effect of NaB on is not present across extinction due to a floor effect, however, this does lead to an attenuation of responding at reinstatement (Castino et al. 2015) .
Histone acetylation
To examine the possible site of action of NaB we assessed H3K14 acetylation in the vmPFC. As illustrated in Fig. 2 , acetylation of H3K14 at the Cdk-5 and BDNF exon I promoter regions was not significantly altered by either exposure to nicotine or treatment with NaB across extinction. In contrast, H3K14ac at the BDNF exon IV promoter was significantly decreased following nicotine self-administration [(F 1,19 ) = 4.681, P < 0.05], an effect that was specific to rats trained to self-administer nicotine, and that received vehicle injections across extinction [(F 1,19 ) = 5.571, P < 0.05; Fc = 4.381].
Histone methylation
We further explored the relationship between nicotine exposure and chromatin modifications through analysis of H3K4 and H3K27 trimethylation (H3K4me3, H3K27me3) and H3K9 dimethylation (H3K9me2) at the Cdk-5 and BDNF exon IV promoters. BDNF exon I was not examined further due to insufficient ChIP sample.
H3K4me3 was unaltered at either the Cdk-5 or BDNF exon IV promoter regions following nicotine or NaB treatment (Fs <1; Fig. 3a) . In contrast, H3K9me2 and H3K27me3 was significantly reduced (indicating permissive chromatin) following a history of nicotine self-administration at the BDNF exon IV promoter [H3K9me2: (F 1,19 ) = 6.145, P < 0.05; H3K27me3: (F 1,19 ) = 7.382, P < 0.05; Fig. 3b,c] . This effect was independent of NaB treatment (Fs <1). A similar pattern was observed for H3K27me3 at the Cdk-5 promoter [(F 1,19 ) = 4.832, P < 0.05], with a strong trend observed for H3K9me2 [(F 1,19 ) = 3.867, P = 0.064].
Gene expression
To determine if the observed chromatin modifications resulted in altered-gene transcription, we assessed expression of BDNF and its isoforms, as well as other plasticity-related genes that may be implicated in the behavioural response to NaB across extinction of nicotine-seeking.
Two patterns of gene expression following nicotine self-administration and extinction with or without NaB treatment were observed (Fig. 4) . Firstly, NaB treatment increased the expression of BDNF exon I [(F 1,20 
Discussion
In a previous study we reported that extinction of nicotine, but not sucrose, self-administration is facilitated by post-session treatment with the HDAC inhibitor NaB (Castino et al. 2015) . We hypothesised that this was due at least in part to nicotine-induced chromatin modifications that persisted across the extinction period. Here, we have showed changes in histone acetylation, histone methylation and gene expression that are associated with NaB treatment, a history of nicotine self-administration or an interaction of both.
Sodium butyrate primarily inhibits activity of the class 1 HDACs (Kilgore et al. 2010) , and influences gene expression at approximately 2% of the mammalian genome (Candido et al. 1978; Davie 2003) . It has been shown to facilitate memory formation and extinction associated with fear conditioning (Lattal et al. 2007) , drug-conditioned place preference (Itzhak et al. 2013; Raybuck et al. 2013 ) and drug self-administration (Castino et al. 2015) . Here, we showed that recent treatment with NaB resulted in the increased expression of several genes, including Cdk-5, BDNF exon I and BDNF exon IX in the vmPFC.
Both Cdk-5 and BDNF play critical roles in the neuronal plasticity necessary for long-term memory formation (Angelo et al. 2006; Bekinschtein et al. 2008) . Cdk-5 regulates dendritic spine morphogenesis and synapse formation through phosphorylation of several pre-and post-synaptic proteins, including glutamatergic receptors, ion channels and intracellular signalling molecules (Angelo et al. 2006; Li & Blow 2001; Plattner et al. 2014) . Through these mechanisms cdk-5 expression has been implicated in the regulation of learning and memory events (Hawasli et al. 2007; Sananbenesi et al. 2007) , as well as the neuronal response to chronic cocaine (Bibb et al. 2001) . Similarly, the neurotrophin BDNF regulates the reorganization of neuronal structure that is essential for long-term memory formation, including the transcriptional and translational processes required for long-term potentiation (Bekinschtein et al. 2008; Tolwani al. 2002) . The impact of NaB on BDNF is consistent with previous findings showing NaB-induced increases in BDNF exon I and IV mRNA that is associated with enhanced performance on memory tasks following exercise (Intlekofer et al. 2013) , and that HDAC inhibitors more generally (e.g. Valproic acid (VPA), Trichostatin A (TSA)) facilitate the transcription of genes necessary for the consolidation of new learning into long-term memory (Bredy et al. 2007; Graff & Tsai 2013; Peixoto & Abel 2013) . These data suggest that Cdk-5 and BDNF may be involved in our previously reported NaB-induced enhancement of extinction learning following nicotine self-administration through increasing transcription of these genes critical for the consolidation of inhibitory control over drug-seeking.
Although changes in gene expression due to NaB may contribute to enhanced extinction of nicotine-seeking, the absence of an effect of NaB on sucrose-seeking suggests an interaction between a history of nicotine and subsequent NaB treatment may be important. Here, we observed evidence of such an interaction at the BDNF IV locus, where NaB-induced increases in BDNF expression was blocked in rats with a history of nicotine exposure. Different isoforms of the BDNF gene display distinct tissue and subcellular localization [i.e. cell body, dendrites (Baj et al. 2011; Timmusk et al. 1993] . The exon IV splice variant of BDNF is an activity-dependent isoform that shows particular activity in response to drugs of abuse (Sadri-Vakili et al. 2010) , suggesting that nicotine may be altering the epigenetic readout of the BDNF IV promoter, reducing the ability of NaB to hyperacetylate this loci.
Histone acetylation at the H3K14 lysine residue in the promoter regions of both Cdk-5 and BDNF exon I and IV was assessed due to its association with memory consolidation (Levenson et al. 2004) , NaB treatment (Raybuck et al. 2013; Stafford et al. 2012 ) and chronic psychostimulant administration (Malvaez et al. 2011; Wang et al. 2010) . Surprisingly, significant changes in histone acetylation were discordant with our detected changes in gene expression. There were no effects of NaB on H3K14ac at either BDNF exon I or Cdk-5 promoter regions, suggesting that the transcription of these genes does not appear to be regulated by H3K14ac in the vmPFC (Heller et al. 2016) . It is possible that under these circumstances, NaB is controlling gene transcription by regulating acetylation at alternate lysine residues. For example, NaB increases H3K18, H4K5 and H4K8 acetylation in rats undergoing reinstatement of heroin-seeking, where NaB also facilities the behavioural response to morphine (Chen et al. 2016) . Clearly, further assessment of global changes in histone acetylation following extinction of nicotine-seeking in combination with additional targeted ChIP-assays would help clarify this issue.
In contrast, acetylation at the BDNF exon IV promoter was significantly decreased in rats that self-administered nicotine, and this is reversed via application of NaB. This is inconsistent with the published literature highlighting nicotine as a 'chromatin relaxer' (Chase & Sharma 2013; Landais et al. 2005; Levine et al. 2011; Satta et al. 2008) , as chronic nicotine appeared to lead to transcriptional repression at this residue. It is likely that a complex interplay between different chromatin marks (including histone methylation as discussed below) occurs, however, it is worth considering that the method of administration may be important. Evidence that nicotine acts as an HDACi comes from acute application of nicotine in vitro (Landais et al. 2005) or relatively brief (7 days) administration via drinking water (Levine et al. 2011) . In contrast, our rats experienced chronic intravenous self-administration, which also occurred in the context of a learning event. Although the consequences of chronic HDAC inhibition, by nicotine or otherwise, have not been widely studied there is some evidence to suggest that chronic HDAC inhibition may lead to compensatory increases in other HDACs or related enzymes. For example, knockdown of HDAC2 leads to upregulation of other HDAC isoforms (Graff et al. 2012) , and hyperacetylation induced via chronic cocaine leads to increased levels of the histone methyltransferase G9a to repress transcription (Kennedy et al. 2013) . Whether such a process may be occurring following chronic nicotine self-administration is not yet known.
As described above, H3K14ac is sensitive to the effects of NaB in a gene-specific manner. In contrast, histone methylation is not affected by NaB, rather, histone methylation appears to encode the drug-taking history of an animal. Assessment of histone methylation at the Cdk-5 and BDNF exon IV promoters showed a significant decrease in methylation of the repressive marks H3K9me2 and H3K27me3 in animals with a history of nicotine self-administration. This decrease was evident despite 6 days of extinction without nicotine administration, and is consistent with a more permissive chromatin structure at both the Cdk-5 and BDNF-IV genes. Decreased methylation at the H3K9 mark following nicotine has been reported previously in vitro and appears to be mediated via direct activity at the nicotinic acetylcholine receptor (nAChR) and as a consequence of repressed histone methyltransferase activity [including GLP, G9a and Setdb1; (Chase & Sharma 2013; Landais et al. 2005) ]. Whether administration of nicotine under our experimental conditions is also mediated via nAChR activation and involves histone methyltransferase inhibition is not known, but our results do support the notion that histone methylation is a durable and persistent modification that may be cumulative across time, and with repeated activity (Jenuwein & Allis 2001; Maze et al. 2010) .
Consistent with previous reports (Bredy et al. 2007; Kumar et al. 2005) , levels of histone acetylation and methylation were often not associated with corresponding changes in gene expression. The ability of HDAC inhibitors (i.e. NaB) to increase histone acetylation is potentiated when the chromatin structure is rendered permissive by the original learning or drug exposure (i.e. nicotine) itself (Bredy et al. 2007; Graff & Tsai 2013) . Across abstinence, heightened responsiveness to nicotine may be encoded at the level of chromatin, rather than in steady-state changes in gene expression. In support of this claim, several studies have now shown that cocaine-induced epigenetic changes alter the inducibility of or 'prime'-specific genes in response to subsequent cue or drug exposures, without affecting their basal levels of expression (Baker-Andresen et al. 2015; Damez-Werno et al. 2012; Massart et al. 2015) . Therefore the nicotine self-administration is leading to changes in histone methylation or acetylation that are not evident in changes in gene transcription following 6 days of extinction, where little or no new learning is occurring. However, when gene expression is initiated (e.g. at reinstatement), the influence of chromatin modifications may now become apparent at the level of transcription. Further studies incorporating reinstatement may help clarify this issue.
It is also important to note that it is difficult to conclusively attribute our observed differences in histone acetylation or methylation to nicotine exposure, as separate from those that may occur due to extinction learning itself. Persistent changes in gene expression and histone modifications have been reported following extinction of conditioned fear (Bredy et al. 2007 ), but also following abstinence from cocaine self-administration where extinction did not occur (Freeman et al. 2008) . Future studies directly comparing epigenetic modifications following extinction vs. abstinence would help clarify this issue.
Together the results from this study suggest that extinction from nicotine self-administration leads to a range of changes in gene expression, histone acetylation and histone methylation. Increased expression of Cdk-5 and BDNF I and IX occurred in response to administration of NaB and contribute to our past studies showing the NaB enhanced extinction learning following nicotine self-administration. An interaction of NaB treatment and nicotine self-administration was associated with altered expression of BDNF IV mRNA and H3K14ac at the BDNF IV promoter, suggesting that expression of BDNF IV may be particularly important in regulating learning and memory processes that occur following drug exposure. Finally, we show for the first time that nicotine self-administration leads to long-lasting changes in demethylation of the repressive marks H3K9me2 and H3K27me3. Nicotine self-administration leads to a range of changes in gene expression that may be controlled in part by regulation of epigenetic factors. It remains to be determined exactly how this occurs, and how these changes contribute to drug-seeking more generally.
